July 14,2006
Chairman Grassley Questions CMS, FDA About Substituted Inhalation Drugs
Please see the printer-friendly version of Chairman Grassley's letter CMS and FDA regarding substituted inhalation drugs.
Next Article Previous Article
Recent News
- Chairman Crapo: One Big Beautiful Bill Delivers on America-First Policies
- Crapo Applauds House Passage of President Trump’s One Big Beautiful Bill
- One Big Beautiful Bill: New Tax Relief Overwhelmingly Benefits Working Class
- Chairman Crapo Statement on Senate Passage of One Big Beautiful Bill Act
- Crapo: Senate Republican Plan Powers Economic Growth, Delivers Tax Relief